Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-02 Sale |
2024-05-03 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
4,681 | $8.7378 | $40,902 | 145,505 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 5:08 pm |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
3,468 | $11.12 | $38,568 | 146,020 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:54 pm |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks |
1,610 | $15.83 | $25,481 | 66,090 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 6:53 pm |
N/A 2035-01-02 |
Ventyx Biosciences Inc. | VTYX | Moore Matthew Richard Chief Operating Officer |
145,000 | $0 | 145,000 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-17 4:20 pm |
N/A 2034-05-16 |
Ventyx Biosciences Inc. | VTYX | Moore Matthew Richard Chief Operating Officer |
320,000 | $0 | 320,000 (Direct) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
4,166 | $0 | 145,505 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 6:47 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
68,232 | $0 | 149,488 (Direct) |
View |
| 2024-01-12 Option Award |
2024-01-17 4:28 pm |
N/A 0034-01-12 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
154,000 | $0 | 180,590 (Direct) |
View |
| 2023-08-29 Option Award |
2023-09-12 07:39 am |
N/A 2031-01-18 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
12,500 | $0 | 12,500 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:54 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks |
54,400 | $0 | 66,090 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:46 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
48,600 | $0 | 48,600 (Direct) |
View |
| 2021-01-19 Option Award |
2021-01-21 8:07 pm |
N/A 2031-01-19 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
160,000 | $0 | 160,000 (Direct) |
View |